AS-3201

· Sumitomo Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AS-3201, covering 2008-01-14 to 2008-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy [Phase 3]